These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34217417)

  • 1. Impact of the suspension and restart of the Dutch breast cancer screening program on breast cancer incidence and stage during the COVID-19 pandemic.
    Eijkelboom AH; de Munck L; Lobbes MBI; van Gils CH; Wesseling J; Westenend PJ; Guerrero Paez C; Pijnappel RM; Verkooijen HM; Broeders MJM; Siesling S;
    Prev Med; 2021 Oct; 151():106602. PubMed ID: 34217417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
    Eijkelboom AH; de Munck L; Vrancken Peeters MTFD; Broeders MJM; Strobbe LJA; Bos MEMM; Schmidt MK; Guerrero Paez C; Smidt ML; Bessems M; Verloop J; Linn S; Lobbes MBI; Honkoop AH; van den Bongard DHJG; Westenend PJ; Wesseling J; Menke-van der Houven van Oordt CW; Tjan-Heijnen VCG; Siesling S;
    J Hematol Oncol; 2021 Apr; 14(1):64. PubMed ID: 33865430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on breast cancer incidence and tumor stage in the Netherlands and Norway: A population-based study.
    Eijkelboom AH; de Munck L; Larsen M; Bijlsma MJ; Tjan-Heijnen VCG; van Gils CH; Broeders MJM; Nygård JF; Lobbes MBI; Helsper CW; Pijnappel RM; Strobbe LJA; Wesseling J; Hofvind S; Siesling S;
    Cancer Epidemiol; 2023 Dec; 87():102481. PubMed ID: 37897970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?
    de Munck L; Fracheboud J; de Bock GH; den Heeten GJ; Siesling S; Broeders MJM
    Int J Cancer; 2018 Aug; 143(4):842-850. PubMed ID: 29574967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands.
    Dinmohamed AG; Cellamare M; Visser O; de Munck L; Elferink MAG; Westenend PJ; Wesseling J; Broeders MJM; Kuipers EJ; Merkx MAW; Nagtegaal ID; Siesling S
    J Hematol Oncol; 2020 Nov; 13(1):147. PubMed ID: 33148289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.
    Nederend J; Duijm LE; Voogd AC; Groenewoud JH; Jansen FH; Louwman MW
    Breast Cancer Res; 2012 Jan; 14(1):R10. PubMed ID: 22230363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the COVID-19 pandemic on the in-hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population-based study.
    Wolfkamp W; Meijer J; van Hoeve JC; van Erning F; de Geus-Oei LF; de Hingh I; Veltman J; Siesling S;
    Cancer Med; 2024 Jan; 13(1):e6861. PubMed ID: 38197670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland.
    O'Driscoll J; Mooney T; Kearney P; Williams Y; Lynch S; Connors A; Larke A; McNally S; O'Doherty A; Murphy L; Bennett KE; Fitzpatrick P; Mullooly M; Flanagan F
    J Med Screen; 2024 Sep; 31(3):182-190. PubMed ID: 38509806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands.
    Toes-Zoutendijk E; Vink G; Nagtegaal ID; Spaander MCW; Dekker E; van Leerdam ME; Siesling S; Lansdorp-Vogelaar I; Elferink MAG;
    Eur J Cancer; 2022 Jan; 161():38-43. PubMed ID: 34915408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged screening interval due to the COVID-19 pandemic and its association with tumor characteristics and treatment; a register-based study from BreastScreen Norway.
    Eijkelboom AH; Larsen M; Siesling S; Nygård JF; Hofvind S; de Munck L
    Prev Med; 2023 Oct; 175():107723. PubMed ID: 37820746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.
    Li T; Nickel B; Ngo P; McFadden K; Brennan M; Marinovich ML; Houssami N
    Breast; 2023 Feb; 67():78-88. PubMed ID: 36646004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
    Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
    Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the COVID-19 pandemic on breast cancer screening and diagnosis in a Brazilian metropolitan area.
    Solla Negrao EM; Cabello C; Conz L; Mauad EC; Zeferino LC; Vale DB
    J Med Screen; 2023 Mar; 30(1):42-46. PubMed ID: 36071628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of the interruption of the Dutch breast cancer screening program due to COVID-19: A modelling study.
    Poelhekken K; Greuter MJW; de Munck L; Siesling S; Brokken FB; de Bock GH
    Prev Med; 2023 Jan; 166():107376. PubMed ID: 36493865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival.
    Aarts MJ; Voogd AC; Duijm LE; Coebergh JW; Louwman WJ
    Breast Cancer Res Treat; 2011 Jul; 128(2):517-25. PubMed ID: 21290176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The projected impact of the COVID-19 lockdown on breast cancer deaths in England due to the cessation of population screening: a national estimation.
    Duffy SW; Seedat F; Kearins O; Press M; Walton J; Myles J; Vulkan D; Sharma N; Mackie A
    Br J Cancer; 2022 May; 126(9):1355-1361. PubMed ID: 35110696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
    Hofvind S; Lee CI; Elmore JG
    Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.